^3H-Thymidine uptake and deoxycytidine deaminase activity are different between diploid and hyperdiploid childhood common acute lymphoblastic leukemia (Englisch)
- Neue Suche nach: Jahns-Streubel, G.
- Neue Suche nach: Mettke, K.
- Neue Suche nach: Unterhalt, M.
- Neue Suche nach: Schleyer, E.
- Neue Suche nach: Jahns-Streubel, G.
- Neue Suche nach: Mettke, K.
- Neue Suche nach: Unterhalt, M.
- Neue Suche nach: Schleyer, E.
- Neue Suche nach: Pieters, R.
- Neue Suche nach: Kaspers, G. J. L.
- Neue Suche nach: Veerman, A. J. P.
In:
Drug resistance in leukemia and lymphoma
;
237-244
;
1997
-
ISBN:
-
ISSN:
- Aufsatz (Konferenz) / Print
-
Titel:^3H-Thymidine uptake and deoxycytidine deaminase activity are different between diploid and hyperdiploid childhood common acute lymphoblastic leukemia
-
Beteiligte:Jahns-Streubel, G. ( Autor:in ) / Mettke, K. ( Autor:in ) / Unterhalt, M. ( Autor:in ) / Schleyer, E. ( Autor:in ) / Pieters, R. / Kaspers, G. J. L. / Veerman, A. J. P.
-
Kongress:International symposium; 2nd, Drug resistance in leukemia and lymphoma ; 1995 ; Amsterdam
-
Erschienen in:Drug resistance in leukemia and lymphoma ; 237-244ADVANCES IN BLOOD DISORDERS ; 3 ; 237-244
-
Verlag:
- Neue Suche nach: Harwood
-
Erscheinungsdatum:01.01.1997
-
Format / Umfang:8 pages
-
Anmerkungen:See also 5185.249 vol 9 no 3 1995 for abstracts
-
ISBN:
-
ISSN:
-
Medientyp:Aufsatz (Konferenz)
-
Format:Print
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis Konferenzband
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Pharmacokinetic resistance in childhood leukemiaPui, C. H. / Relling, M. V. / Masson, E. / Rivera, G. K. et al. | 1997
- 9
-
Regrowth resistance as a mechanism for comprehensive growth resistance and fins expression and treatment outcome in acute myelogenous leukemiaPreisler, H. D. / Raza, A. / Hegde, U. / Handa, H. et al. | 1997
- 19
-
Pharmacological classification of cytotoxic drug resistance phenotypes in blast cells from patients with acute myelocytic leukemia: Identification of a topoisomerase II inhibitor sensitive and vincaalkaloid resistant cellular phenotypeKristensen, J. / Nygren, P. / Loefvenberg, E. / Killander, A. et al. | 1997
- 33
-
The use of the MTT assay to study drug resistance in acute myeloid leukemia: an updateSargent, J. / Elgie, A. / Williamson, C. / Bowen, S. et al. | 1997
- 43
-
Drug resistance determined with a short-term culture assay is related to clinical outcome and to cell biological features in childhood lymphoblastic leukemiaVeerman, A. J. P. / Kaspers, G. J. L. / Klumper, E. / Pieters, R. et al. | 1997
- 51
-
Tailored therapy for relapsed or refractory childhood acute lymphoblastic leukemiaAgthe, A. G. / Doerffel, W. / Neuendank, A. / Hartmann, R. et al. | 1997
- 59
-
In vitro assay results of 15 children with Philadelphia chromosome positive acute lymphoblastic leukemia and their clinical outcomesHongo, T. / Matsushita, T. / Ogawa, N. / Yajima, S. et al. | 1997
- 65
-
The response of tumor cells to doxorubicin - a comparison of the MTT assay and three other resistance assaysLangkjer, S. T. / Ebbehoej, E. / Noergaard, J. M. et al. | 1997
- 73
-
Effects of cyclosporin A and SDZ-PSC 833 on formazan production by peripheral blood lymphocytesWacker, P. / Gardiol, N. / Wyss, M. et al. | 1997
- 77
-
The favourable prognostic value of CD34 expression in childhood acute lymphoblastic leukemia is related to in vitro drug sensitivityVan der Woude, C. J. / Greve, M. / Pieters, R. / Veerman, A. J. P. et al. | 1997
- 85
-
Acid phosphatase positive non-high risk leukemia is associated with a worse prognosis which can not be explained by drug resistanceZwaan, C. M. / Den Boer, M. L. / Van Zantwijk, C. H. / Rottier, M. M. A. et al. | 1997
- 95
-
Glucocorticoid sensitivity and resistance in childhood leukemiaKaspers, G. J. L. / Pieters, R. / Veerman, A. J. P. et al. | 1997
- 105
-
Corticosteroid resistance: an important biological difference between childhood and adult acute lymphoblastic leukemiaMaung, Z. T. / Reid, M. M. / Proctor, S. J. / Thylor, P. R. A. et al. | 1997
- 115
-
The relationship between bcl-2 expression and response to chemotherapy in acute leukemiaMaung, Z. T. / Maclean, F. R. / Reid, M. M. / Pearson, A. D. J. et al. | 1997
- 123
-
Recombinant human stem cell factor protects CD34 positive human myeloid leukemia cells from the chemotherapy-induced apoptosisHassan, H. T. / Freund, M. et al. | 1997
- 129
-
Diminished apoptosis of tumor cells in large cell cutaneous T-cell lymphomas. Consequences for cell biological behaviour and therapy resistanceVan Haselen, C. W. / Toonstra, J. / Van der Putte, S. C. J. / Van Vloten, W. A. et al. | 1997
- 141
-
Apoptosis of B-chronic lymphocytic leukemia (CLL) cells in presence of glucocorticoids and modulation of their effect by interleukin-4Tanghe, A. / Delforge, A. / Bernier, M. / Massy, M. et al. | 1997
- 147
-
Clinical relevance of mechanisms of thiopurine resistance in childhood leukemiaLennard, L. et al. | 1997
- 157
-
Competition between 6-mercaptopurine and hypoxanthine during a tumor lysis syndromeKeuzenkamp-Jansen, C. W. / De Abreu, R. A. / Lambooy, M. A. H. / Boekkerink, J. P. M. et al. | 1997
- 163
-
Biochemical basis for increased susceptibility for 6-mercaptopurine and synergistic cytotoxicity after treatment with methotrexateBoekkerink, J. P. M. / De Abreu, R. A. et al. | 1997
- 173
-
Sensitivity for novel antifolates in childhood leukemia cells with resistance to methotrexateBekkenk, M. / Mauritz, R. / Pieters, R. / Rots, M. et al. | 1997
- 183
-
High-dose methotrexate for the treatment of acute lymphoblastic leukemia in children (a pharmacokinetic study)Slany, J. / Grundmann, M. / Brozmanova, H. / Blazek, B. et al. | 1997
- 189
-
Relation of cellular drug sensitivity to pharmacology of cytosine-arabinoside-5'-triphosphate in malignant and normal cellsKoehl, U. / Schwabe, D. / Ebenel, U. / Wehner, S. et al. | 1997
- 203
-
In vitro studies of growth factors in combination with cytostatic drugs on human leukemic cellsSundman-Engberg, B. / Tidefelt, U. / Paul, C. et al. | 1997
- 209
-
Effects of cytokines and their combinations with Ara-C on short term culture of tumor cells from children with acute leukemia by the MTT-assayMetelitsa, L. / Shmelev, V. / Shredova, E. / Popov, A. et al. | 1997
- 217
-
Fludarabine and gemcitabine interaction with cytosine-arabinoside on human acute myeloid leukemia cellsBernabei, P. A. / Santini, V. / D'Ippolito, G. / Rossi-Ferrini, P. et al. | 1997
- 223
-
Gemcitabine and gemcitabine plus Ara-C have significant activity on blast cells from patients with blast crisis chronic myeloproliferative disordersSantini, V. / Bernabei, P. A. / D'Ippolito, G. / Figuccia, M. et al. | 1997
- 229
-
Modulation of Cytosine Arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic cellsNoordhuis, P. / Kazemier, K. M. / Kaspers, G. J. L. / Peters, G. J. et al. | 1997
- 237
-
^3H-Thymidine uptake and deoxycytidine deaminase activity are different between diploid and hyperdiploid childhood common acute lymphoblastic leukemiaJahns-Streubel, G. / Mettke, K. / Unterhalt, M. / Schleyer, E. et al. | 1997
- 245
-
In vitro and in vivo cytotoxicity of fludarabine in patients with advanced stage B-cell chronic lymphocytic leukemia (B-CLL)Hilgenfeld, E. / Knauf, W. U. / Thiel, E. et al. | 1997
- 255
-
Evaluation of techniques for PGP determination in clinical leukemia specimensRedman, K. L. / Twentyman, P. R. et al. | 1997
- 265
-
Polymerase chain reaction related approaches to quantitate absolute levels of mRNA coding for the multidrug resistance-associated protein and P-glycoproteinKoehler, T. / Lassner, D. / Rost, A.-K. / Leiblein, S. et al. | 1997
- 275
-
Functional assessment of multidrug resistance gene (MDR1) in hematologic malignancies using rhodamine 123Rund, D. / Fibach, E. / Polliack, A. et al. | 1997
- 281
-
LRP and vault-related multidrug resistanceScheffer, G. L. / Izquierdo, M. A. / Flens, M. J. / Wijngaard, P. L. J. et al. | 1997
- 289
-
MDR-1 induction during successful alkylating chemotherapy in multiple myelomaRaaijmakers, H. G. P. / Izquierdo, M. A. / Belien, J. A. M. / Scheper, R. J. et al. | 1997
- 299
-
Immunocytochemical evaluation of the multidrug resistance phenotype in acute leukemia and multiple myeloma at diagnosis: prognostic relevance and relationship to proliferative activityMusto, P. / Matera, R. / Carotenuto, M. et al. | 1997
- 307
-
Development of a highly sensitive multiparameter flow cytometric assay correlating MDR1 expression and function: clinical application to acute myeloid leukemiaLeith, C. P. / Kopecky, K. J. / Chen, I. M. / Appelbaum, F. R. et al. | 1997
- 315
-
Expression of multidrug resistance-associated protein (MRP) gene in acute myeloid leukemia and correlation with expression of multidrug resistance (MDR1) geneZhou, D. C. / Zittoun, R. / Marie, J. P. et al. | 1997
- 325
-
Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) gene in chronic lymphocytic leukemiaHart, S. M. / Ganeshaguru, K. / Hoffbrand, A. V. / Mehta, A. B. et al. | 1997
- 333
-
Expression of the multidrug resistance-associated protein (MRP) gene in hematological malignanciesBurger, H. / Nooter, K. / Van Wingerden, K. E. / Oostrum, R. G. et al. | 1997
- 345
-
Multifactorial resistance in patients with acute myeloid leukemia (AML): coexpression of P-glycoprotein, the multidrug-resistance related protein (MRP) as well as heat shock proteinsKasimir-Bauer, S. / Stellberg, W. / Schardt, C. / Meusers, P. et al. | 1997
- 353
-
Expression of heat shock proteins (HSP 27, HSP 60, HSP 70, HSP 90) in patients with low grade lymphomasSchardt, C. / Kasimir-Bauer, S. / Nowrousian, M. R. / Opalka, B. et al. | 1997
- 359
-
Expression and prognostic significance of resistance proteins in initial childhood acute lymphoblastic leukemiaSauerbrey, A. / Volm, M. / Zintl, F. et al. | 1997
- 367
-
Prognostic value of activity of rhodamine-efflux in pediatric leukemiasSommaggio, A. / Ricciardi, M. R. / Maurillo, L. / Spinelli, M. et al. | 1997
- 375
-
Daunorubicin uptake and retention in childhood acute lymphoblastic leukemiaDen Boer, M. L. / Pieters, R. / Kazemier, K. M. / Klumper, E. et al. | 1997
- 387
-
Expression of class glutathione S-transferase correlates with event free survival in childhood acute lymphoblastic leukemiaMatheson, E. / Norton, J. / Kearns, P. / Hall, A. et al. | 1997
- 395
-
Correlation between early anthracycline dose intensity and clinical outcome identifies specific chemo-resistance patterns in adult acute lymphoblastic leukemiaBassan, R. / Rambaldi, A. / Lerede, T. / Borleri, G. et al. | 1997
- 403
-
Modulation of drug resistanceTwentyman, P. R. et al. | 1997
- 413
-
In vitro effect of myeloid growth factors oil the cytotoxicity of daunorubicinNoergaard, J. M. / Langkjer, S. T. / Ellegaard, J. / Palshof, T. et al. | 1997
- 421
-
In vitro study of PKC modulators in acute myeloid leukemiaElgie, A. / Sargent, J. / Taylor, C. et al. | 1997
- 429
-
Dexverapamil as resistance modifier in acute myeloid leukemiaPirker, R. / Zoechbauer, S. / Kupper, H. / Lassmann, A. et al. | 1997
- 435
-
~1-acid glycoprotein and multidrug resistanceWoodcock, B. G. / Keese, A. / Harder, S. / Ganser, A. et al. | 1997
- 443
-
Kinetic evidence that progesterone stimulates and inhibits P-glycoprotein activity at low and at high concentrations respectivelyVan Acker, K. L. / Delforge, M. R. / De Greef, C. / Eggermont, J. et al. | 1997
- 455
-
Contribution of specific DNA repair pathways to drug resistance in CLL patientsMueller, M. R. / Thomale, J. / Buschfort, C. / Lensing, C. et al. | 1997
- 465
-
Hematopoietic growth factors, vincristine uptake and cytotoxicity in AMLKeese, A. / Harder, S. / Woodcock, B. G. et al. | 1997
- 471
-
Tumor cell resistance against mitoxantrone under acidic pH conditionsWoessmann, W. / Siemens, A. / Wiencke, A. / Wiedemann, G. et al. | 1997